david findlay
david findlay
Professor of Orthopaedic Research, University of Adelaide
Adresse e-mail validée de adelaide.edu.au
Citée par
Citée par
The Nitrogen‐Containing Bisphosphonate, Zoledronic Acid, Influences RANKL Expression in Human Osteoblast‐Like Cells by Activating TNF‐α Converting Enzyme (TACE)
B Pan, AN Farrugia, LB To, DM Findlay, J Green, K Lynch, ...
Journal of Bone and Mineral Research 19 (1), 147-154, 2004
Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway
AR Wijenayaka, M Kogawa, HP Lim, LF Bonewald, DM Findlay, GJ Atkins
PloS one 6 (10), e25900, 2011
Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors.
N Udagawa, N Takahashi, T Katagiri, T Tamura, S Wada, DM Findlay, ...
Journal of Experimental Medicine 182 (5), 1461-1468, 1995
Vascular pathology and osteoarthritis
DM Findlay
Rheumatology 46 (12), 1763-1768, 2007
Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1α, 25-dihydroxyvitamin D3
GJ Atkins, PH Anderson, DM Findlay, KJ Welldon, C Vincent, ...
Bone 40 (6), 1517-1528, 2007
Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint
DR Haynes, TN Crotti, M Loric, GI Bain, GJ Atkins, DM Findlay
Rheumatology 40 (6), 623-630, 2001
Biocompatible polymer coating of titania nanotube arrays for improved drug elution and osteoblast adhesion
K Gulati, S Ramakrishnan, MS Aw, GJ Atkins, DM Findlay, D Losic
Acta biomaterialia 8 (1), 449-456, 2012
RANKL expression is related to the differentiation state of human osteoblasts
GJ Atkins, P Kostakis, B Pan, A Farrugia, S Gronthos, A Evdokiou, ...
Journal of Bone and Mineral Research 18 (6), 1088-1098, 2003
Receptor activator of nuclear factor-κB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivo
AN Farrugia, GJ Atkins, LB To, B Pan, N Horvath, P Kostakis, DM Findlay, ...
Cancer research 63 (17), 5438-5445, 2003
Zoledronic acid protects against osteosarcoma‐induced bone destruction but lacks efficacy against pulmonary metastases in a syngeneic rat model
A Labrinidis, S Hay, V Liapis, DM Findlay, A Evdokiou
International journal of cancer 127 (2), 345-354, 2010
PM Sexton, DM Findlay, TJ Martin
Current medicinal chemistry 6 (11), 1067-1093, 1999
The proliferation and phenotypic expression of human osteoblasts on tantalum metal
DM Findlay, K Welldon, GJ Atkins, DW Howie, ACW Zannettino, D Bobyn
Biomaterials 25 (12), 2215-2227, 2004
Sclerostin is a locally acting regulator of late‐osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE‐ASARM‐dependent mechanism
GJ Atkins, PS Rowe, HP Lim, KJ Welldon, R Ormsby, AR Wijenayaka, ...
Journal of Bone and Mineral Research 26 (7), 1425-1436, 2011
The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis
DR Haynes, TN Crotti, AE Potter, M Loric, GJ Atkins, DW Howie, ...
The Journal of bone and joint surgery. British volume 83 (6), 902-911, 2001
Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response
GJ Atkins, KJ Welldon, P Halbout, DM Findlay
Osteoporosis International 20 (4), 653-664, 2009
Expression of osteoclast differentiation signals by stromal elements of giant cell tumors
GJ Atkins, DR Haynes, SE Graves, A Evdokiou, S Hay, S Bouralexis, ...
Journal of Bone and Mineral Research 15 (4), 640-649, 2000
Receptor activator NF-κB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients …
TN Crotti, MD Smith, H Weedon, MJ Ahern, DM Findlay, M Kraan, PP Tak, ...
Annals of the rheumatic diseases 61 (12), 1047-1054, 2002
Characterization of an osteoblast-like clonal cell line which responds to both parathyroid hormone and calcitonin
SM Forrest, KW Ng, DM Findlay, VP Michelangeli, SA Livesey, ...
Calcified Tissue International 37 (1), 51-56, 1985
Osteoprotegerin (OPG) is localized to the Weibel‐Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor
ACW Zannettino, CA Holding, P Diamond, GJ Atkins, P Kostakis, ...
Journal of cellular physiology 204 (2), 714-723, 2005
Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: Expression of receptor activator NFκB, RANK ligand and osteoprotegerin
TN Crotti, MD Smith, DM Findlay, H Zreiqat, MJ Ahern, H Weedon, ...
Biomaterials 25 (4), 565-573, 2004
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20